PureTech launches Seaport, hoping to create Karuna 2.0

Apr 9, 2024  · Hoping to repeat a recent success story, the biotechnology startup creator PureTech Health has launched a new company aimed at developing psychiatric medicines. …


Install CouponFollow Chrome Extension   CouponFollow Extension

$100
OFF

PureTech Launches Seaport Therapeutics With $100 Million …

1 week from now

Apr 9, 2024  · Seaport will be led by Daphne Zohar along with Founder Steven M. Paul, M.D., who is the former Chief Executive officer of Karuna Therapeutics ("Karuna"), another CNS-focused …

yahoo.com

$225
OFF

Brain Drug Developer Seaport Raises Another $225M

1 week from now

Oct 21, 2024  · Launched in April, Seaport Therapeutics wants to create psychiatry medicines that last longer and cause fewer side effects. The company was founded by PureTech Health, the …

biopharmadive.com

$100
OFF

Seaport Therapeutics Launches With $100 Million Oversubscribed …

1 week from now

Apr 9, 2024  · Daphne Zohar, the Chief Executive Officer of Seaport, is the founder and former CEO of PureTech Health where she also co-founded Karuna Therapeutics. Under Ms. Zohar’s …

seaporttx.com

$225
OFF

Seaport, Six Months Out Of Stealth, Comes Back For $225M Raise

1 week from now

Oct 21, 2024  · Seaport is run by executives from Karuna, which was bought by Bristol Myers Squibb last year for $14 billion. The medicine at the center of that deal, KarXT, was just …

biospace.com

$100
OFF

PureTech Launches Seaport Therapeutics With $100 Million …

1 week from now

Apr 9, 2024  · Seaport’s business and assets are described in more detail in the press release issued by Seaport. . Includes participation by top tier biotech investors ARCH Venture …

pharmiweb.com

$100
OFF

Seaport Therapeu Cs Launches With $100 Million …

1 week from now

Apr 9, 2024  · Seaport Therapeu cs Launches with $100 Million Oversubscribed Series A Financing Round to Advance Novel Neuropsychiatric Medicines . Daphne Zohar, Founding …

seaporttx.com

$100
OFF

PureTech Founded Entity Seaport Therapeutics Adds Industry …

1 week from now

May 7, 2024  · The appointments follow the recent launch of Seaport, PureTech's newest Founded Entity, with a $100 million Series A financing round. Consistent with its model, PureTech …

puretechhealth.com

$100
OFF

PureTech Launches Seaport Therapeutics With $100 Million …

1 week from now

Apr 9, 2024  · Bharatt Chowrira, Ph.D., J.D., named Chief Executive Officer of PureTech; PureTech Co-founder, Eric Elenko, Ph.D., promoted to President PureTech Founding Chief ...

marketscreener.com

$100
OFF

Seaport Therapeutics Launches With $100M Series A

1 week from now

Apr 9, 2024  · Seaport Therapeutics, the eighth and latest of the “founded entities” companies to be created by PureTech Health, formally launched today with an oversubscribed $100 million …

genengnews.com

$100
OFF

Seaport Debuts With $100M Series A, As Psychiatric Boom Grows

1 week from now

Apr 9, 2024  · Seaport raised $100 million in a Series A round, with backers including the same investors who initially funded Karuna, namely ARCH Venture Partners, Sofinnova …

statnews.com

$18
OFF

PureTech Calls New Spinout Seaport Therapeutics 'Karuna On …

1 week from now

Mar 22, 2024  · Daphne Zohar, PureTech’s founder and CEO, said the company directed $18.5 million to the founding and development of Karuna. She said PureTech’s total return for its …

bizjournals.com

$225
OFF

Seaport Loads $225M For Karuna Vets' Voyage To Milestones

1 week from now

Oct 21, 2024  · Karuna’s former CEO Steven Paul, M.D., serves as the chair of Seaport’s board of directors. The biotech was assembled by PureTech Health —where Zohar was previously …

fiercebiotech.com

$225
OFF

Seaport Eyes Platform, Pipeline Growth With $225M Series B

1 week from now

Oct 21, 2024  · Seaport is the latest of the “founded entity” companies to be created by PureTech Health. Zohar previously led PureTech, whose R&D effort created 29 therapeutics and …

genengnews.com

$100
OFF

Seaport Therapeutics Launches With $100 Million Oversubscribed …

1 week from now

Apr 9, 2024  · Seaport has exclusively licensed this technology from Monash University based on the pioneering research of the Porter research group, along with the co-inventors from …

businesswire.com

3%
OFF

Karuna - Puretech Health

1 week from now

1 As of March 22, 2023, PureTech has sold its right to receive a 3% royalty from Karuna to Royalty Pharma on net sales up to $2 billion annually, after which threshold PureTech will …

puretechhealth.com

FAQs about PureTech launches Seaport, hoping to create Karuna 2.0 Coupon?

Does PureTech own seaport Therapeutics?

1 As of October 18, 2024, PureTech’s percentage ownership of Seaport Therapeutics was approximately 36.7% on a partially diluted basis. This calculation includes outstanding shares, options, and warrants, but excludes unallocated shares authorized to be issued pursuant to equity incentive plans. ...

Who is the new Chief Executive Officer of PureTech?

Bharatt Chowrira, Ph.D., J.D., named Chief Executive Officer of PureTech; PureTech Co-founder, Eric Elenko, Ph.D., promoted to President PureTech Founding Chief Executive Officer, Daphne Zohar, to lead Seaport as Chief Executive Officer, together with former Karuna Chief Executive Officer and Chair, Steven M. Paul, M.D., as Chairman ...

Can PureTech develop non-CNS Therapies utilizing the glyph platform?

PureTech retains the right to develop non-CNS therapies utilizing the Glyph platform, subject to certain contractual constraints. Seaport Therapeutics is advancing the development of novel neuropsychiatric medicines in areas of high unmet patient needs. ...

Does seaport's neuropsychiatric medicine pipeline drive value for PureTech?

Consistent with its model, PureTech internally advanced Seaport’s neuropsychiatric medicines programs to a key inflection point, and the pipeline – which is now being advanced by Seaport – can drive value for PureTech through an equity stake and license consideration. ...

Why has PureTech not been able to raise money in public markets?

Chowrira said PureTech hasn’t had to raise money in the public markets for about six years because its spinouts provide a source of cash back to the company to further fuel its innovation. Join the Boston Business Journal for our 8th annual Business of Pride event! ...

Is seaport working on a new antidepressant?

A phase 2a trial has validated this proof of concept, said Seaport, which hopes to develop SPT-300 as a treatment for anxious depression. Seaport is also working on SPT-320, a prodrug of agomelatine—an antidepressant available in Europe as Valdoxan but not approved by the FDA. ...

Install CouponFollow Extension on Chrome

Install the CouponFollow extension to search for discount codes when shopping the fastest!

Install CouponFollow Chrome Extension   Install CouponFollow Chrome Extension